Sort
261,768 grants matching “gene therapy”
Center for Systems-level Study of Metastasis
$1,696,261Sohail F. Tavazoie · Rockefeller University · U54 · FY2021 · CA
Molecular Approaches To Antiviral and Vaccine Development For Viral Hepatitis and Other Viral Diseases
$1,696,123T. Jake Liang · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2021 · DK
Targeting REV-ERB to treat Alzheimer's disease
$1,695,972Thomas P Burris · St. Louis College Of Pharmacy · RF1 · FY2019 · AG
Gene Therapy:Translating Basic Science to the Clinic
$1,695,763University Of California San Diego · P01 · FY2003 · HL
The Epilepsy Bioinformatics Study for Antiepileptogenic Therapy (EpiBioS4Rx) Project 2: Preclinical Model for Antiepileptogenic Therapy Screening in Post-traumatic Epilepsy
$1,695,679Aristea S Galanopoulou · University Of Southern California · U54 · FY2020 · NS
Hormonal Control of Calcium Metabolism
$1,695,496John T Potts · Massachusetts General Hospital · P01 · FY2017 · DK
Protein Kinase Therapeutic Targets for Non-Small Cell Lung Carcinoma
$1,695,312Matthew L Meyerson · Dana-Farber Cancer Inst · P01 · FY2014 · CA
SCOR: Pathobiology of Fibrotic Lung Disease
$1,695,210National Jewish Health · P01 · FY2001 · HL
NATIONAL GENE VECTOR LABORATORY AT INDIANA UNIVERSITY
$1,694,989Indiana Univ-Purdue Univ At Indianapolis · U42 · FY2002 · RR
Adjuvant Enhanced Antiviral Immunity
$1,694,391Jeff C Fairman · Juvaris Biotherapeutics, Inc. · U01 · FY2009 · AI
Molecular Determinants of Chromosome Transmission and Cell Cycle Regulation
$1,694,185Munira Basrai · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA
Identification and Characterization of Signaling Pathways and Mediators Regulating Mast Cell-Related Disorders
$1,694,050Dean D Metcalfe · National Institute Of Allergy And Infectious Diseases · ZIA · FY2021 · AI
The Pathogenesis, Diagnosis, And Treatment of Systemic Mast Cell Disorders
$1,694,050Dean D Metcalfe · National Institute Of Allergy And Infectious Diseases · ZIA · FY2021 · AI
Therapeutic vaccination and PD-1 blockade in treated HIV disease
$1,693,836Steven Grant Deeks · University Of California, San Francisco · U01 · FY2019 · AI
Circumventing Barriers to Effective Oncolytic Virotherapy of Malignant Gliomas
$1,693,572Jianhua Yu · Ohio State University · P01 · FY2017 · CA
Primate Lentivirus Pathogenesis
$1,693,237Malcolm Martin · National Institute Of Allergy And Infectious Diseases · Z01 · FY2008 · AI
Neuronal Ion Channel Modulation By Second Messengers
$1,692,978Stephen R Ikeda · Alcohol Abuse And Alcoholism · Z01 · FY2007 · AA
Evaluation of a dual PPAR agonist for treatment of Alzheimer's disease
$1,692,440James Cardelli · Oleolive, Inc. · R42 · FY2022 · AG
Translational Studies of Inherited Marrow Failure and Myelodysplastic Syndromes
$1,692,348Akiko Shimamura · Fred Hutchinson Cancer Research Center · R24 · FY2013 · DK
Using Clinical Pharmacology Principles to Develop New Anticancer Therapies
$1,692,241William Douglas Figg · Division Of Clinical Sciences - Nci · ZIC · FY2023 · CA
Integrative Biology of Tumor Metastasis
$1,692,056Rakesh K. Jain · Massachusetts General Hospital · R01 · FY2009 · CA
GENES, ANEUPLOIDY AND MAMMALIAN DEVELOPMENT
$1,692,045Johns Hopkins University · P01 · FY2004 · HD
UCLA Center for AIDS Research (CFAR)
$1,691,762University Of California Los Angeles · P30 · FY2004 · AI
SPORE in Breast Cancer
$1,691,744Henry Shelton Earp · Univ Of North Carolina Chapel Hill · P50 · FY2013 · CA
Center of Research Translation on Osteoporosis Bone Anabolic Therapies
$1,691,716Marc Nathan Wein · Massachusetts General Hospital · P50 · FY2023 · AR